Delivery Order 36C25726D0032-36C25726N0164
- Not listed
- Cepheid has been awarded a delivery order valued at $341,103.30 for Cepheid Molecular Diagnostic Testing System Reagents and Assays under the Veterans Integrated Service Network (VISN) 6 Indefinite Delivery, Indefinite Quantity (IDIQ) contract. This firm fixed-price delivery order was awarded on October 14, 2025, with an ultimate completion date of March 31, 2026. The contract carries no set-aside designation and is funded by the Department of Veterans Affairs through VISN 6. Cepheid, a...
- Cepheid Inc., a leading manufacturer of molecular diagnostic systems based in Sunnyvale, California, was awarded a delivery order valued at $970,216.62 on October 1, 2025, for Cepheid Molecular Diagnostic Testing System reagents and assays supporting Veterans Integrated Service Network 6 (VISN 6). This firm fixed-price delivery order, which extends through March 31, 2026, carries no set-aside designation and will be performed in Sunnyvale, California. The award funds the supply of molecular...
- Cepheid was awarded a delivery order valued at $172,259.87 for Cepheid reagents by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 16 on October 1, 2024. This firm fixed-price contract, with an ultimate completion date of September 30, 2025, carries no set-aside designation. The work will be performed in Sunnyvale, California. Cepheid is a leading manufacturer of molecular diagnostic solutions specializing in advanced diagnostic systems and test kits for infectious...
- The Department of Veterans Affairs, Veterans Integrated Service Network 9, awarded a delivery order valued at $168,685.49 to Cepheid Inc. for Cepheid reagents for patient testing, effective November 1, 2025, with an ultimate completion date of September 30, 2026. This firm fixed-price delivery order carries no set-aside designation and represents a reconnection of funding and procurement routing to support continued reagent delivery under an existing vehicle. Cepheid, a for-profit molecular...
- This delivery order, awarded to Cepheid Inc. on October 1, 2024, represents a $204,172.08 firm fixed-price contract to supply molecular diagnostic reagents to the Department of Veterans Affairs' Veterans Integrated Service Network 23. The order is scheduled for completion by September 30, 2025, with work performed at Cepheid's Sunnyvale, California facility. The award carries no set-aside designation and is issued without the involvement of major subcontractors identified in the award...
- The Department of Veterans Affairs, Veterans Integrated Service Network 8, awarded a delivery order to Cepheid Inc. valued at $115,369.40 for Cepheid GeneXpert Infinity molecular reagents. The contract, awarded on October 1, 2025, has a firm fixed-price structure with an ultimate completion date of March 31, 2026. This delivery order carries no set-aside designation and represents procurement under an existing Indefinite Delivery Vehicle, enabling VISN 8 to obtain molecular diagnostic testing...
- The Department of Veterans Affairs, Veterans Integrated Service Network (VISN) 6 awarded a delivery order to Cepheid Inc. for Cepheid Molecular Diagnostic Testing System Reagents and Assays valued at $537,017.20, effective October 1, 2025, with an ultimate completion date of March 31, 2026. This firm fixed-price delivery order was awarded without set-aside designation and represents a task order issued under Cepheid's larger IDV vehicle with VISN 6, which holds a total ceiling value of $32.8...
- Cepheid has been awarded a delivery order valued at approximately $310K for molecular diagnostic testing system reagents and assays supporting Veterans Integrated Service Network 6 (VISN 6), a component of the Department of Veterans Affairs' healthcare system. This firm fixed-price delivery order, with no set-aside designation, will be performed through March 31, 2026, and represents a continuation of Cepheid's ongoing supply of diagnostic solutions to the VA's regional health networks. The...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 16 (VISN 16), awarded a firm fixed-price purchase order to Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, with a ceiling value of $1.2M and a completion date of September 30, 2030. This contract covers Cepheid reagents and related molecular diagnostic testing solutions. The award carries no set-aside designation and reflects VISN 16's ongoing procurement of advanced diagnostic...
- The Department of Veterans Affairs, Veterans Integrated Service Network 10, awarded a $192,866.10 firm fixed-price purchase order to Cepheid Inc. for reagents with an ultimate completion date of February 28, 2026. The contract, which carries no set-aside designation, involves the addition of two line items to support molecular diagnostic testing capabilities. Cepheid, a Sunnyvale, California-based manufacturer specializing in molecular diagnostic solutions, will deliver these reagents to the...
- 36C25726D0032Indefinite Delivery Contract
- 36C25726D0032-36C25726N0164Delivery Order
The Department of Veterans Affairs, Veterans Integrated Service Network 17, awarded a delivery order to Cepheid Inc. valued at $1.56M for the provision of reagents and diagnostic solutions under the Cepheid Reagents Contract for Ordering Period 1. This firm fixed-price delivery order, which carries no set-aside designation, is scheduled for completion by December 21, 2026. Cepheid, a Sunnyvale, California-based manufacturer of molecular diagnostic systems, will fulfill this order through its Sunnyvale facility, leveraging its established expertise in advanced diagnostic technologies and reagent supply for federal healthcare systems. This delivery order draws from Cepheid's broader federal presence within the Veterans Health Administration, where the company maintains multiple indefinite delivery vehicles enabling ongoing procurement of molecular diagnostic solutions. The company's core offerings include GeneXpert diagnostic systems, PCR testing reagents, and assays designed to detect infectious diseases such as COVID-19, influenza, RSV, and other conditions critical to VA medical operations. As a firm fixed-price contract with no set-aside designation, this award reflects Cepheid's competitive standing in the federal molecular diagnostics procurement market and supports VISN 17's laboratory and clinical testing capabilities.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
6550--NEW - Cepheid Reagents Contract | 36C25726Q0029 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 | Special Notice 1/1 | 10/2/25, 4:45 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6m | 12/19/25 |